Longeveron (LGVN) Interest Coverage Ratio (2020 - 2022)
Longeveron (LGVN) recorded quarterly Interest Coverage Ratio of 3.75 in Q4 2022, up 99.91% quarter-over-quarter from 4032.0 in Q4 2021, and up 99.91% on a YoY basis from 1.88 in Q4 2021.
Longeveron (LGVN) Interest Coverage Ratio (2020 - 2022) Analysis & Trends
Longeveron's Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 3.75 for Q4 2022.
- In Q4 2022, Interest Coverage Ratio rose 99.91% year-over-year to 3.75; the TTM figure through Sep 2023 stood at 14.91 (up 99.91% YoY), while the FY2022 annual figure was 12.91, up 99.7% from the prior year.
- Interest Coverage Ratio was 3.75 for Q4 2022 at Longeveron, up from 4032.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.75 in Q4 2022 to a low of 4905.0 in Q3 2021.
- Historically, Interest Coverage Ratio has averaged 2028.71 across 3 years, with a median of 1496.0 in 2020.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio tumbled 1948.02% in 2021, then jumped 99.91% in 2022.
- A 3-year view of Interest Coverage Ratio shows it stood at 461.0 in 2020, then sank by 774.62% to 4032.0 in 2021, then surged by 99.91% to 3.75 in 2022.
- The last three Interest Coverage Ratio figures came in at 3.75 (Q4 2022), 4032.0 (Q4 2021), and 4905.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3.75 |
| Dec 31, 2021 | -4,032.00 |
| Sep 30, 2021 | -4,905.00 |
| Jun 30, 2021 | -2,531.00 |
| Dec 31, 2020 | -461.00 |
| Sep 30, 2020 | -239.50 |